L13. Apoptosis, Apoptotic cell clearance and resolution of inflammation

Presse Medicale

Volumn 42, Issue 4 PART2, 2013, Pages 536-537

  Rossi, Adriano G ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 9; CYCLIN DEPENDENT KINASE INHIBITOR; INTERLEUKIN 10; LIPOXIN; PROTEIN MCL 1;

APOPTOSIS; CELL FUNCTION; DENDRITIC CELL; EFFEROCYTOSIS; EOSINOPHIL; GRANULOCYTE; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; LETTER; MACROPHAGE; NEOPLASM; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS;

EID: 84875607020     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2013.01.012     Document Type: Letter

References (20)

1. Gilroy D.W., Lawrence T., Perretti M., Rossi A.G. Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 2004, 3(5):401-416.
2. Serhan C.N., Brain S.D., Buckley C.D., Gilroy D.W., Haslett C., O'Neill L.A., et al. Resolution of inflammation: state of the art, definitions and terms. FASEB J 2007, 21(2):325-332.
3. Duffin R., Leitch A.E., Fox S., Haslett C., Rossi A.G. Targeting granulocyte apoptosis: mechanisms, models, and therapies. Immunol Rev 2010, 236:28-40.
4. Fox S., Leitch A.E., Duffin R., Haslett C., Rossi A.G. Neutrophil apoptosis: relevance to the innate immune response and inflammatory disease. J Innate Immun 2010, 2(3):216-227.
5. Witko-Sarsat V., Pederzoli-Ribeil M., Hirsch E., Sozzani S., Cassatella M.A. Regulating neutrophil apoptosis: new players enter the game. Trends Immunol 2011, 32(3):117-124.
6. Nathan C. Points of control in inflammation. Nature 2002, 420(6917):846-852. 19-26.
7. Ley K., Laudanna C., Cybulsky M.I., Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007, 7(9):678-689.
8. Nathan C., Ding A. Nonresolving inflammation. Cell 2010, 140(6):871-882.
9. Maskrey B.H., Megson I.L., Whitfield P.D., Rossi A.G. Mechanisms of resolution of inflammation: a focus on cardiovascular disease. Arterioscler Thromb Vasc Biol 2011, 31(5):1001-1006.
10. Dorward D.A., Lucas C.D., Rossi A.G., Haslett C., Dhaliwal K. Imaging inflammation: molecular strategies to visualize key components of the inflammatory cascade, from initiation to resolution. Pharmacol Ther 2012, 135(2):182-199.
11. Hallett J.M., Leitch A.E., Riley N.A., Duffin R., Haslett C., Rossi A.G. Novel pharmacological strategies for driving inflammatory cell apoptosis and enhancing the resolution of inflammation. Trends Pharmacol Sci 2008, 29(5):250-257.
12. Rossi A.G., Sawatzky D.A., Walker A., Ward C., Sheldrake T.A., Riley N.A., et al. Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat Med 2006, 12(9):1056-1064.
13. Duffin R., Leitch A.E., Sheldrake T.A., Hallett J.M., Meyer C., Fox S., et al. The CDKR-inhibitor roscovitine, promotes eosinophil apoptosis by down-regulation of Mcl-1. FEBS Lett 2009, 583(15):2540-2546.
14. Alessandri A.L., Duffin R., Leitch A.E., Lucas C.D., Sheldrake T.A., Dorward D.A., et al. Induction of eosinophil apoptosis by the cyclin-dependent kinase inhibitor AT7519 promotes the resolution of eosinophil-dominant allergic inflammation. PLoS One 2011, 6(9):e25683.
15. Leitch A.E., Lucas C.D., Marwick J.A., Duffin R., Haslett C., Rossi A.G. Cyclin-dependent kinases 7 and 9 specifically regulate neutrophil transcription and their inhibition drives apoptosis to promote resolution of inflammation. Cell Death Differ 2012, 19(12):1950-1961.
16. Leitch A.E., Haslett C., Rossi A.G. Cyclin-dependent kinase inhibitor drugs as potential novel anti-inflammatory pro-resolution agents. Br J Pharmacol 2009, 158(4):1004-1016.
17. Lucas C.D., Allen K.C., Dorward D.A., Hoodless L.J., Melrose L.A., Marwick J.A., et al. Flavones induce neutrophil apoptosis by down-regulation of Mcl-1 via a proteasomal-dependent pathway. FASEB J 2013, 27(3):1084-1094.
18. Leitch A.E., Riley N.A., Sheldrake T.A., Festa M., Fox S., Duffin R., et al. The cyclin-dependent kinase inhibitor R-roscovitine down-regulates Mcl-1 to override pro-inflammatory signalling drive neutrophil apoptosis. Eur J Immunol 2010, 40(4):1127-1138.
19. Michlewska S., Dransfield I., Megson I.L., Rossi A.G. Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro-inflammatory anti-inflammatory agents: key role for TNF-alpha. FASEB J 2009, 23(3):844-854.
20. Liu Y., Cousin J.M., Hughes J., Van Damme J., Seckl J.R., Haslett C., et al. Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J Immunol 1999, 162(6):3639-3646.